The Global Veterinary Oncology Market comprises therapeutic products, diagnostic technologies, and clinical services designed for the prevention, diagnosis, treatment, and monitoring of cancer in companion animals. The market includes Chemotherapy, Radiation Therapy, Surgical Oncology, Immunotherapy, Targeted Therapy, and Palliative & Supportive Care solutions that improve treatment outcomes, extend survival rates, and enhance quality of life for veterinary patients.
The Global Veterinary Oncology Market was valued at approximately USD 1,180 million in 2025 and is projected to reach around USD 2,920 million by 2035, expanding at a CAGR of 9.5% during the forecast period. Market growth is primarily driven by the rising incidence of cancer in companion animals, increasing pet healthcare expenditure, growing adoption of advanced oncology therapies, and continuous advancements in targeted therapy, immunotherapy, and precision veterinary medicine. Expanding awareness among pet owners and greater access to specialty veterinary care are further accelerating market growth.
The report considers 2021-2024 historic period, 2025 as base year, and 2026-2035 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Veterinary Oncology market report is based on a robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other benchmarking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Veterinary Oncology market is estimated to expand at a considerable growth rate during the forecast period owing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Veterinary Oncology products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restrict the adoption of Veterinary Oncology products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Veterinary Oncology market.
To learn more about this report
Increasing research and development spending on Veterinary Oncology development has been the leading industry trend of Veterinary Oncology market
The leading players in the market are focused on developing products which are cost-effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be witnessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2025 | USD XX.XX Million |
| CAGR (2026 - 2035) | XX.XX % |
| The Revenue forecast in 2035 | USD XX.XX Million |
| Base year for estimation | 2025 |
| Historical data | 2021-2024 |
| Forecast period | 2026-2035 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Therapy Outlook, End-User Outlook, Regional Outlook |
| By Therapy Outlook | Chemotherapy, Radiation Therapy, Surgical Oncology, Immunotherapy, Targeted Therapy, Palliative & Supportive Care |
| By End-User Outlook | Veterinary General Hospitals, Veterinary Specialty Oncology Hospitals, Veterinary Diagnostic Laboratories, Academic & Research Institutions |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | AB Science, Accuray Incorporated, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, Elanco Animal Health, IDEXX Laboratories, Karyopharm Therapeutics, Merck Animal Health, PetCure Oncology, Varian Medical Systems (Siemens Healthineers), Zoetis |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
